SCHEDULE: Alyeska Investment Group Discloses 4.75% Stake in Hinge Health

Sentiment:

Beneficial Ownership Disclosure (Schedule 13G Amendment)


Alyeska Investment Group, L.P. and its affiliates reported beneficial ownership of 4.75% of Hinge Health, Inc.'s Class A Common Stock as of September 30, 2025.

Summary

  • Alyeska Investment Group, L.P., Alyeska Fund GP, LLC, and Anand Parekh collectively reported beneficial ownership of 1,293,007 shares of Hinge Health, Inc.'s Class A Common Stock.
  • This ownership represents 4.75% of the total outstanding Class A Common Stock.
  • The beneficial ownership is reported as of September 30, 2025.
  • The percentage calculation assumes 37,919,155 outstanding shares of Class A Common Stock, based on Hinge Health, Inc.'s Form 10-Q filed on November 7, 2025.
  • The reporting persons certified that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 5

Explanation: The filing is a routine disclosure of beneficial ownership by an investment group, indicating a passive stake below the 5% threshold. It does not contain information that would significantly alter the company's operational or financial outlook.

Positives

  • Institutional investment group Alyeska Investment Group, L.P. holds a significant stake, indicating potential confidence in Hinge Health, Inc.
  • The filing explicitly states the securities are held in the ordinary course of business and not for influencing control, suggesting a passive investment.

Negatives

  • The reported stake of 4.75% is below the 5% threshold that would typically trigger more active reporting requirements (Schedule 13D), indicating a passive position.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

  • Shareholders: The disclosure of institutional ownership by Alyeska Investment Group may be viewed positively by some shareholders as a sign of institutional confidence, though the stake is passive and below 5%.

Key Dates

DateDescription
08/14/2025Filing date of the Schedule 13G Amendment No. 1.
09/30/2025Date of event which requires filing of this statement and the date as of which beneficial ownership is reported.
11/07/2025Date of Hinge Health, Inc.'s Form 10-Q used for outstanding shares calculation.

Keywords

Hinge Health, Alyeska Investment Group, Class A Common Stock, beneficial ownership, SEC filing, Schedule 13G, institutional investment, healthcare technology

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.